Gene expression analysis of soft tissue sarcomas: characterization and reclassification of malignant fibrous histiocytoma

Helman, 2003, Mechanisms of sarcoma development, Nat Rev Cancer, 3, 685, 10.1038/nrc1168 Hasegawa, 2002, Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas, Hum Pathol, 33, 111, 10.1053/hupa.2002.30184 Fletcher, 1992, Pleomorphic malignant fibrous histiocytoma: fact or fiction? A critical reappraisal based on 159 tumors diagnosed as pleomorphic sarcoma, Am J Surg Pathol, 16, 213, 10.1097/00000478-199203000-00001 Hollowood, 1995, Malignant fibrous histiocytoma: morphologic pattern or pathologic entity?, Semin Diagn Pathol, 12, 210 Fletcher, 2001, Clinicopathologic re-evaluation of 100 malignant fibrous histiocytomas: prognostic relevance of subclassification, J Clin Oncol, 19, 3045, 10.1200/JCO.2001.19.12.3045 Fletcher, 2002, Pleomorphic malignant fibrous histiocytoma/undifferentiated high grade pleomorphic sarcoma, 120 Nielsen, 2002, Molecular characterisation of soft tissue tumours: a gene expression study, Lancet, 359, 1301, 10.1016/S0140-6736(02)08270-3 Nagayama, 2002, Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray, Cancer Res, 62, 5859 Lee, 2003, Molecular classification of synovial sarcomas, leiomyosarcomas and malignant fibrous histiocytomas by gene expression profiling, Br J Cancer, 88, 510, 10.1038/sj.bjc.6600766 Segal, 2003, Classification and subtype prediction of adult soft tissue sarcoma by functional genomics, Am J Pathol, 163, 691, 10.1016/S0002-9440(10)63696-6 Skubitz, 2004, Characterization of sarcomas by means of gene expression, J Lab Clin Med, 144, 78, 10.1016/j.lab.2004.04.005 Baird, 2005, Gene expression profiling of human sarcomas: insights into sarcoma biology, Cancer Res, 65, 9226, 10.1158/0008-5472.CAN-05-1699 Takahashi, 2006, Cancer diagnosis marker extraction for soft tissue sarcomas based on gene expression profiling data by using projective adaptive resonance theory (PART) filtering method, BMC Bioinform, 7, 399, 10.1186/1471-2105-7-399 Hasegawa, 2003, Expression of smooth muscle markers in so called malignant fibrous histiocytomas, J Clin Pathol, 56, 666, 10.1136/jcp.56.9.666 Skubitz, 2005, Differential gene expression in liposarcoma, lipoma, and adipose tissue, Cancer Invest, 23, 105, 10.1081/CNV-50432 Segal, 2005, Identification of cancer-testis genes expressed by melanoma and soft tissue sarcoma using bioinformatics, Cancer Immun, 5, 2 Derre, 2001, Leiomyosarcomas and most malignant fibrous histiocytomas share very similar comparative genomic hybridization imbalances: an analysis of a series of 27 leiomyosarcomas, Lab Invest, 81, 211, 10.1038/labinvest.3780229 Coindre, 2004, Inflammatory malignant fibrous histiocytomas and dedifferentiated liposarcomas: histological review, genomic profile, and MDM2 and CDK4 status favour a single entity, J Pathol, 203, 822, 10.1002/path.1579 Mentzel, 1996, Myxofibrosarcoma: clinicopathologic analysis of 75 cases with emphasis on the low-grade variant, Am J Surg Pathol, 20, 391, 10.1097/00000478-199604000-00001 Pennica, 1998, WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors, Proc Natl Acad Sci USA, 95, 14717, 10.1073/pnas.95.25.14717 Brigstock, 2003, The CCN family: a new stimulus package, J Endocrinol, 178, 169, 10.1677/joe.0.1780169 Perbal, 2004, CCN proteins: multifunctional signalling regulators, Lancet, 363, 62, 10.1016/S0140-6736(03)15172-0 Kierszenbaum, 2003, Epididymal G protein-coupled receptor (GPCR): two hats and a two-piece suit tailored at the GPS motif, Mol Reprod Dev, 64, 1, 10.1002/mrd.10224 Obermann, 2003, HE6, a two-subunit heptahelical receptor associated with apical membranes of efferent and epididymal duct epithelia, Mol Reprod Dev, 64, 13, 10.1002/mrd.10220 Kirchhoff, 2006, Role of epididymal receptor HE6 in the regulation of sperm microenvironment, Mol Cell Endocrinol, 250, 43, 10.1016/j.mce.2005.12.023 Burch, 1997, Tenascin-X deficiency is associated with Ehlers-Danlos syndrome, Nat Genet, 17, 104, 10.1038/ng0997-104 Schalkwijk, 2001, A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency, N Engl J Med, 345, 1167, 10.1056/NEJMoa002939 Mao, 2002, Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition, Nat Genet, 30, 421, 10.1038/ng850